Literature DB >> 21956663

Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia.

Yoshikazu Nishi1, Kazuko Hamamoto2, Naoto Fujita2, Satoshi Okada3.   

Abstract

Radiation-induced empty sella (ES) or pituitary atrophy/small pituitary and endocrine impairments, including pituitary and gonadal dysfunction, can manifest decades after radiation and chemotherapy in childhood-onset leukemia patients who received prophylactic cranial irradiation or total body irradiation in preparation for bone marrow transplant. Six childhood-onset leukemia patients (age at diagnosis of leukemia; 2.7-10.2 years) participated in this study. Magnetic resonance imaging (MRI) of the pituitary gland and endocrinological studies were performed 10.5-32.1 years after cranial irradiation. In four of the six patients examined, ES or pituitary atrophy was detected approximately 10.5-19.8 years after cranial irradiation. Four patients had hypogonadism (primary, 3; hypothalamic-pituitary, 1) and one had primary hypothyroidism. We conclude that ES or pituitary atrophy and endocrine impairments can manifest decades after radiation and chemotherapy in childhood-onset leukemia. These patients should, therefore, undergo regular follow-up, including pituitary MRI and hormonal examinations.

Entities:  

Mesh:

Year:  2011        PMID: 21956663     DOI: 10.1007/s12185-011-0939-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

Review 1.  Endocrine late effects of cancer treatment.

Authors:  Laurie E Cohen
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

2.  Height of normal pituitary gland on MR imaging: age and sex differentiation.

Authors:  M Suzuki; T Takashima; M Kadoya; H Konishi; T Kameyama; J Yoshikawa; T Gabata; K Arai; S Tamura; T Yamamoto
Journal:  J Comput Assist Tomogr       Date:  1990 Jan-Feb       Impact factor: 1.826

3.  MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium.

Authors:  A Tsunoda; O Okuda; K Sato
Journal:  AJNR Am J Neuroradiol       Date:  1997-03       Impact factor: 3.825

Review 4.  Hypopituitarism as a consequence of brain tumours and radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

5.  Primary empty sella.

Authors:  Laura De Marinis; Stefania Bonadonna; Antonio Bianchi; Giulio Maira; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2005-06-21       Impact factor: 5.958

6.  Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.

Authors:  S Cannavò; L Curtò; M Venturino; S Squadrito; B Almoto; M C Narbone; R Rao; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 7.  Long-term follow-up of survivors of childhood cancer.

Authors:  Angela B Edgar; Elizabeth M M Morris; Christopher J H Kelnar; Hamish B Wallace
Journal:  Endocr Dev       Date:  2009-03-03

Review 8.  Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group.

Authors:  Radha Nandagopal; Caroline Laverdière; Daniel Mulrooney; Melissa M Hudson; Lillian Meacham
Journal:  Horm Res       Date:  2007-12-05
  8 in total
  3 in total

1.  Dynamics of fertility impairment in childhood brain tumour survivors.

Authors:  C Pfitzer; C-M Chen; T Wessel; T Keil; A Sörgel; T Langer; D Steinmann; A Borgmann-Staudt
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-20       Impact factor: 4.553

2.  Pituitary magnetic resonance imaging abnormalities in young female patients with hypogonadotropic hypogonadism.

Authors:  Ji-Yeon Kang; Sang Heum Kim; Hounyoung Kim; Hyojin Ki; Mee-Hwa Lee
Journal:  Obstet Gynecol Sci       Date:  2019-06-21

3.  Clinical ascertainment of health outcomes in Asian survivors of childhood cancer: a systematic review.

Authors:  Long Hin Jonathan Poon; Chun-Pong Yu; Liwen Peng; Celeste Lom-Ying Ewig; Hui Zhang; Chi-Kong Li; Yin Ting Cheung
Journal:  J Cancer Surviv       Date:  2019-05-04       Impact factor: 4.442

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.